MiNK Therapeutics Inc. (NASDAQ: INKT) Stock Information | RedChip

MiNK Therapeutics Inc. (NASDAQ: INKT) Listen to this Section


$0.81
-0.0160 ( -1.95% ) 40.8K

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Market Data


Open


$0.81

Previous close


$0.82

Volume


40.8K

Market cap


$31.88M

Day range


$0.81 - $0.84

52 week range


$0.75 - $1.90

Insider Ownership Transactions

Total Amount Purchased: -63,464.00 | $ -51,088.52

Date Type Amount Purchased Purchaser
2023-12-05 Sale -17068.00 Ryan Barbara
2023-12-05 Sale -17188.00 Corvese Brian
2023-12-05 Sale -14424.00 WIINBERG ULF
2023-12-05 Sale -14784.00 Behner Peter

SEC Fillings


Form Type Description Pages Date
ars Annual reports 1 Apr 30, 2024
def Proxies and info statements 3 Apr 29, 2024
8-k 8K-related 15 Mar 21, 2024
10-k Annual reports 71 Mar 21, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
8-k 8K-related 12 Feb 29, 2024
8-k 8K-related 12 Feb 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.